NCT02328690

Brief Summary

The purpose of this prospective, double-blind, repeated measures study is to assess the efficacy of Binaural Beat Technology (BBT) on anxiety and anxiety related cardiovascular measures as well as to assess the feasibility of implementing a BBT intervention in a military population during the high risk post-deployment window.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
74

participants targeted

Target at P25-P50 for not_applicable anxiety

Timeline
Completed

Started Jun 2012

Longer than P75 for not_applicable anxiety

Geographic Reach
1 country

2 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

June 1, 2012

Completed
2.5 years until next milestone

First Submitted

Initial submission to the registry

December 18, 2014

Completed
13 days until next milestone

First Posted

Study publicly available on registry

December 31, 2014

Completed
6 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 1, 2015

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

July 1, 2015

Completed
Last Updated

May 30, 2017

Status Verified

May 1, 2017

Enrollment Period

3.1 years

First QC Date

December 18, 2014

Last Update Submit

May 25, 2017

Conditions

Keywords

binaural beat technologysound technologycardiovascular stress responsemilitarymusicanxietystress

Outcome Measures

Primary Outcomes (5)

  • C-Reactive Protein

    C-reactive protein is a biomarker of the inflammatory process.

    Before the intervention and again at 5 weeks

  • State-Trait Anxiety (STAI)

    The STAI will be used to measure overall generalized anxiety as well as current state anxiety immediately before and after the intervention. The instrument consists of 40 4-point Likert scale statements (20 related to trait anxiety and 20 related to state anxiety). Scores range from 40 to 160 with the higher score depicting a higher level of anxiety.

    Before the intervention and again at 5 weeks

  • Morning Blood Pressure/Evening Blood Pressure Decline

    Using an ambulatory blood pressure (BP) monitor, BP measures will be taken every 60 minutes starting from two hours before bedtime and ending two hours after rising. Morning BP surge will be assessed by comparing the trend of the number of millimeters of mercury (mm Hg) the BP increased during the first two hours after rising. Evening BP decline will be assessed by comparing the trend of the percentage that the BP declined while sleep when compared the mean awake BP.

    Before the intervention, at 2 weeks and again at 4 weeks

  • Cardiovascular Reactivity

    Continuous heart rate measures will be taken during five states: 1) at baseline, 2) during the training for a cognitive challenge, 3) during the cognitive challenge, 4) during recovery, and 5) when verbally coached to relax. When analyzed via the computer, a high variability response will indicate a healthy autonomic system whereas a low variability response will indicate evidence of chronic stress exposure.

    Before the intervention and again at 5 weeks

  • Post Intervention Questionnaire

    The Post Intervention Questionnaire will be used to collect qualitative data (3 questions to address efficacy and 11 questions to address feasibility). This instrument will be used in conjunction with field notes during recruitment to assess: 1) retention, 2) number of refusal during recruitment, 3) number of drop outs, 4) reason for drop out, 5) reason for staying, 6) number of day the technology was used (more or less than prescribed recommendation), 7) selection of music, 8) ease of use and comfort of equipment (e.g., sleep phone, mp3 player, etc), 9) adherence to the protocol, and 10) evaluation of recruitment strategies.

    At 5 weeks

Study Arms (2)

Music with BBT

EXPERIMENTAL

Music embedded with special tones.

Other: Binaural Beat Technology

Music without BBT

PLACEBO COMPARATOR

Music not embedded with special tones.

Other: Binaural Beat Technology

Interventions

A phenomenon when two nearly similar frequencies (between 30-1000 hertz \[Hz\]) are presented to each ear and the brain detects the difference between the two sounds. These two sounds are processed in the superior olivary nucleus of each hemisphere of the brain. This integration of brain hemispheres produces a frequency that in turn affects the reticular activating system which alters the electrical potentials of the thalamus and cerebral cortex changing brainwave frequency.

Also known as: Hemi-Sync
Music with BBTMusic without BBT

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Military personnel who
  • Have deployed
  • Are eligible to receive healthcare at WRNMMC or FBCH
  • Are 18 years and older
  • Are able to commit to a 5-week study

You may not qualify if:

  • Military personnel who…
  • Are taking any medication in the anti-hypertensive category
  • Are taking any medication in the anti-anxiety category
  • Have been diagnosed with moderate or severe traumatic brain injury
  • Have a history of epilepsy
  • Are taking any medication in the anti-seizure category
  • Have hearing deficit and/or wear a hearing aide

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

Walter Reed National Military Medical Center

Bethesda, Maryland, 20889, United States

Location

Fort Belvoir Community Hospital

Fort Belvoir, Virginia, 22060, United States

Location

MeSH Terms

Conditions

Anxiety Disorders

Condition Hierarchy (Ancestors)

Mental Disorders

Study Officials

  • MeLisa Gantt, PhD

    Gantt Clinical Research Institute LLC

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, INVESTIGATOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
FED
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
(former) Chief, Research Program

Study Record Dates

First Submitted

December 18, 2014

First Posted

December 31, 2014

Study Start

June 1, 2012

Primary Completion

July 1, 2015

Study Completion

July 1, 2015

Last Updated

May 30, 2017

Record last verified: 2017-05

Locations